MRKR News and Press, Marker Therapeutics Inc. From 06/13/23

2023-06-13 10:10:06 ET Gainers: First Wave BioPharma ( FWBI ) +150% . YS Biopharma ( YS ) +20% . Akoya Biosciences ( AKYA ) +17% . Evoke Pharma ( EVOK ) +16% . Surmodics ( SRDX ) +16% . Losers: Jin Medical International ( ...

HOUSTON, June 12, 2023 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced that t...

2023-06-09 14:37:00 ET Gainers: Blue Apron Holdings ( APRN ) +65% . Sientra ( SIEN ) +50% . ContraFect ( CFRX ) +43% . Global Indemnity ( GBLI ) +23% . Disc Medicine Opco ( IRON ) +21% . Olema Pharmaceuticals ( OLMA ) +...

Marker Therapeutics, Inc. (NASDAQ: MRKR) is one of today's top gainers. The company's shares are currently up 13.94% on the day to $2.37. Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapie...

2023-06-01 08:30:01 ET Okta OKTA -19% after Q1earning release . Lexicon Pharmaceuticals ( LXRX ) -18% announces pricing of $125 Million public offering and concurrent private placement. C3.ai AI -17% after Q4 earning release . Victoria's Secret &...

2023-06-01 06:00:00 ET 3 Tips for Using Fundamental Analysis to Trade Penny Stocks Penny stocks, often defined as shares trading for less than $5, present a unique opportunity for investors seeking high potential returns. Despite their low market price, these stocks can offer significan...

2023-05-31 10:05:20 ET Gainers: Marker Therapeutics ( MRKR ) +34% . Nano-X Imaging ( NNOX ) +13% . Zai Lab ( ZLAB ) +9% . Invivyd ( IVVD ) +8% . Corbus Pharmaceuticals ( CRBP ) +7% . Losers: Belite Bio ( BLTE ) ...

HOUSTON, May 31, 2023 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced pre-cli...

2023-05-08 08:49:36 ET Clinical-stage immuno-oncology company, Marker Therapeutics ( NASDAQ: MRKR ) appoints of Monic Stuart, M.D., as its new Chief Medical Officer. Dr. Stuart brings more than 20 years of experience as a clinician-scientist and drug develop...

HOUSTON, May 08, 2023 (GLOBE NEWSWIRE) -- Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company focusing on developing next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today announced the app...